Cargando…

P1474: MOLECURAL MECHANISM OF CHEMOTHERAPEUTIC HYDROXYUREA IS MEDIATED BY NOS2

Detalles Bibliográficos
Autores principales:	Dragojević, T., Mitrović Ajtić, O., Diklić, M., Subotički, T., Đikić, D., Živković, E., Čokić, V., Vukotić, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429250/ http://dx.doi.org/10.1097/01.HS9.0000848752.48359.16

Ejemplares similares

PB1858: INFLUENCE OF INFLAMMATION ON ANGIOGENIC FACTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Mitrović Ajtić, O., et al.
Publicado: (2022)

Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia
por: Mitrović Ajtić, Olivera, et al.
Publicado: (2022)

P1002: ANTI-FIBROTIC ACTIVITY OF BMP2 IN BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS OF MYELOPROLIFERATIVE NEOPLASMS
por: Subotički, T., et al.
Publicado: (2022)

Nitric Oxide Synthase Dependency in Hydroxyurea Inhibition of Erythroid Progenitor Growth
por: Subotički, Tijana, et al.
Publicado: (2021)

Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia
por: Đikić, Dragoslava, et al.
Publicado: (2022)

Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro
por: Kapor, Sunčica, et al.
Publicado: (2021)

VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms
por: Subotički, Tijana, et al.
Publicado: (2021)

Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms
por: Vukotić, Milica, et al.
Publicado: (2022)

PB1832: INFLAMMATION INDUCED COAGULATION IN ACUTE MYELOID LEUKEMIA
por: Ajtić, Olivera Mitrović, et al.
Publicado: (2023)

Nitric Oxide Mediation in Hydroxyurea and Nitric Oxide Metabolites’ Inhibition of Erythroid Progenitor Growth
por: Subotički, Tijana, et al.
Publicado: (2021)

Sex Differences and Cytokine Profiles among Patients Hospitalized for COVID-19 and during Their Recovery: The Predominance of Adhesion Molecules in Females and Oxidative Stress in Males
por: Mitrović-Ajtić, Olivera, et al.
Publicado: (2023)

P1653: INFLAMMATION MEDIATED THROMBUS FORMATION IN LYMPHOMAS
por: Antic, Darko, et al.
Publicado: (2023)

Quality of Life in Post-COVID-19 Patients after Hospitalization
por: Mitrović-Ajtić, Olivera, et al.
Publicado: (2022)

P1474: HEMOLYTIC MARKERS, MORTALITY, AND THROMBOEMBOLIC EVENTS IN CAD: RISK ASSESSMENT BY TIME PERIOD SINCE DIAGNOSIS
por: Hill, Quentin A, et al.
Publicado: (2023)

PB2162: INCREASED OXIDATIVE STRESS IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Antic, D., et al.
Publicado: (2022)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

P1437: ASSESSING THE ROLE OF MICRORNAS IN HYDROXYUREA -MEDIATED HBF INDUCTION IN HAEMOGLOBINOPATHIES PATIENTS
por: Kargutkar, Neha, et al.
Publicado: (2023)

Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway
por: Čokić, Vladan P., et al.
Publicado: (2015)

La España de los Reyes Católicos, 1474-1520 /
por: Edwards, John, 1949-
Publicado: (2001)

La España de los Reyes Católicos, 1474-1516
por: Suárez Fernández, Luis
Publicado: (1983)

1474. Etiology of Pulmonary Granulomas: How Common is Unsuspected Infection?
por: Alvarez, Barbara, et al.
Publicado: (2018)

P-075: HYDROXYUREA: EFFECTS ON TREATMENT OF CHILDREN WITH HEMOGLOBINOPATHY SC
por: A., CAMPOS, et al.
Publicado: (2022)

Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?
por: Kapor, Sunčica, et al.
Publicado: (2021)

Shoutai pills improve the quality of oocytes exposed to the chemotherapeutic drug Hydroxyurea
por: Zhang, Yuwei, et al.
Publicado: (2020)

P-018: MILESTONES ALONG MY PERSONAL JOURNEY WITH HYDROXYUREA
por: A., SHAKIR
Publicado: (2022)

1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020)

1474. Getting to Zero: Our Journey to Decrease CABG Deep Sternal Wound Infections
por: Gentile, Paul M, et al.
Publicado: (2023)

P1425: SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Bhat, Varsha, et al.
Publicado: (2023)

P-034: EFFECTS OF HYDROXYUREA ON SKELETAL MUSCLE MICROVASCULATURE OF MICE WITH SICKLE CELL DISEASE
por: M., RICCETTI, et al.
Publicado: (2022)

P1489: MANAGEMENT OF SICKLE CELL DISEASE WITH HYDROXYUREA: A SYSTEMATIC REVIEW FROM LOW- AND MIDDLE-INCOME COUNTRIES
por: Paintsil, V., et al.
Publicado: (2022)

P1046: TREATMENT COMPARISON OF HYDROXYUREA VS RUXOLITINIB IN ESSENTIAL THROMBOCYTHEMIA (ET): A MATCHED COHORT ANALYSIS
por: Grunwald, Michael, et al.
Publicado: (2023)

P-048: INFLUENCE OF SEVEN GENETIC POLYMORPHISMS ON THE RESPONSE TO SICKLE CELL DISEASE THERAPY WITH HYDROXYUREA
por: O., FRANCO SANTOS, et al.
Publicado: (2022)

P1446: HYDROXYUREA AND LIMB ULCERS: IS IT WORTH SUSPENDING? RETROSPECTIVE COHORT STUDY OF BRAZILIAN ADULT PATIENTS WITH SICKLE CELL DISEASE
por: Benites, Bruno, et al.
Publicado: (2023)

The Value of Haematological Parameters and Tumour Markers in the Prediction of Intestinal Obstruction in 1474 Chinese Colorectal Cancer Patients
por: Cao, Yinghao, et al.
Publicado: (2020)

P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
por: F., GALACTÉROS, et al.
Publicado: (2022)

P102: PLASMA FREE HEMOGLOBIN AND REACTIVE OXYGEN SPECIES IN SICKLE CELL ANAEMIA PATIENTS UNDER HYDROXYUREA AND GLUTAMINE THERAPY
por: Giannaki, A, et al.
Publicado: (2022)

1474. Epidemiology and Outcomes of Hospitalized Patients with Urinary Tract Infections (UTI) Due to Multidrug-Resistant Organisms (MDRO)
por: Lahrman, Frances J, et al.
Publicado: (2019)

Chronic psychological stress activates BMP4-dependent extramedullary erythropoiesis
por: Vignjević, Sanja, et al.
Publicado: (2014)

P1541: CONVALESCENCE NEW LIQUID COOLING THERAPY ON PREVENTION AND TREATMENT OF CHEMOTHERAPEUTIC ORAL MUCOSITIS
por: He, Yang, et al.
Publicado: (2023)

Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer
por: London, Cheryl A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uqiljbajbjk103ue2tb8b63fnd